Naoki Inubashiri

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Combination Therapy

Epstein Barr Virus

Health Insurance

Hodgkin Lymphoma

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Takashi Mizuoka, Hiroyuki Sakamaki, Shigeo Fuji, Shota Saito, Tatsunori Murata, Shinya Ohno, Naoki Inubashiri, Tomoha Oshima, Kazuhito Yamamoto
Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan. Journal of medical economics (2023)